Dermatology Doctors in Sewell, NJ Accepting Medicare

6 Dermatology doctors found. Showing 1 - 6

Elana Tova Segal, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Kings Way E Ste A3, Washington Pavilions, Sewell, NJ 08080 Phone: 856-589-3331    Fax: 856-589-3416

Kehua Li, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 570 Egg Harbor Rd, Suite C-1, Sewell, NJ 08080 Phone: 856-256-8899    Fax: 856-256-8868

Gregory Blase Persichetti, D.O. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Kings Way E, Suite A-3, Sewell, NJ 08080 Phone: 856-589-3331    Fax: 856-589-3416

Booth Hammond Durham, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 570 Egg Harbor Rd Ste C1, Sewell, NJ 08080 Phone: 856-256-8899

Rachel Bognet, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 570 Egg Harbor Rd, Suite C-1, Sewell, NJ 08080 Phone: 856-256-8899    Fax: 856-256-8868

Jonathan Winter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Kings Way E, Washington Pavilions Suite A-3, Sewell, NJ 08080 Phone: 856-589-3331    Fax: 856-589-3416

News Archive

Targeting children may be an effective use of limited supplies of flu vaccine

Targeting children may be an effective use of limited supplies of flu vaccine, according to research funded by the Wellcome Trust and the EU. The study suggests that, used to support other control measures, this could help control the spread of pandemics such as the current swine flu.

Embryonic cell implantation improves motor skills in patients with Parkinson's disease

Patients with Parkinson disease (PD) who underwent treatment involving embryonic cell implantation had better motor functioning after their procedures than PD patients who did not receive embryonic cells

Patheon's special meeting of shareholders to be held as announced on December 15, 2009

The Special Committee of Independent Directors of Patheon Inc. announced that Joaquin Viso and Olga Lizardi have agreed to adjourn on consent the previously disclosed Court application they commenced on September 2, 2009 seeking an order requiring that a special meeting of shareholders (the "Requisitioned Meeting") in response to their previously announced requisition be held no later than October 30, 2009.

Study suggests possibility of developing personalized treatments for brain cancer

DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led comprehensive genomic analysis of more than 700 brain tumors has revealed one such subtype of the most malignant brain tumor, called glioblastoma, or GBM. This subtype possesses thousands of tumor-specific DNA errors or mutations instead of dozens observed in most glioblastoma cases. It is also associated with longer survival.

Study describes new pharmacological resistance to colon cancer

Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.

Read more Medical News

› Verified 2 days ago